Science and Research

Pulmonary hypertension in HFpEF and HFrEF: Pathophysiology, diagnosis, treatment approaches

Pulmonary hypertension (PH) is a frequent hemodynamic condition that is highly prevalent in patients with heart failure and reduced (HFrEF) or preserved ejection fraction (HFpEF). Irrespective of left ventricular EF, the presence of PH and right ventricular (RV) dysfunction are highly relevant for morbidity and mortality in patients with heart failure. While elevated left-sided filling pressures and functional mitral regurgitation primarily lead to post-capillary PH, current guidelines and recommendations distinguish between isolated post-capillary PH (IpcPH) and combined post- and pre-capillary PH (CpcPH), the latter being defined by a pulmonary vascular resistance (PVR) of >/=3 Wood units. Here, we describe the pathophysiology and clinical relevance of these distinct entities, and report on the diagnostic work-up including remote pulmonary artery pressure (PAP) monitoring. Furthermore, we highlight strategies to manage PH and improve RV function in heart failure, which may include optimized management of HFrEF and HFpEF (medical and interventional), sufficient volume control, catheter-based mitral valve repair, and-in selected cases-targeted PH therapy. In this context, we also highlight gaps in evidence and the need for further research.

  • Rosenkranz, S.
  • Kramer, T.
  • Gerhardt, F.
  • Opitz, C.
  • Olsson, K. M.
  • Hoeper, M. M.

Keywords

  • *Heart Failure/complications
  • Humans
  • *Hypertension, Pulmonary/complications
  • Prognosis
  • Stroke Volume
  • Ventricular Function, Right
  • HFpEF
  • HFrEF
  • Heart failure
  • Pulmonary hypertension
  • Therapy
Publication details
DOI: 10.1007/s00059-019-4831-6
Journal: Herz
Pages: 483-490 
Number: 6
Work Type: Original
Location: BREATH
Disease Area: PH
Partner / Member: MHH
Access-Number: 31317203
See publication on PubMed

DZL Engagements

chevron-down